|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yokozaki H, Kuniyasu H, Semba S, Yasui W
and Tahara E: Molecular bases of human stomach carcinogenesisMol
Pathol Gastroenterol Cancer. Tahara E: Springer-Verlag; Tokyo: pp.
55–70. 1997
|
|
3
|
Kuniyasu H, Yasui W, Yokozaki H and Tahara
E: Helicobacter pylori infection and carcinogenesis of the
stomach. Langenbecks Arch Surg. 385:69–74. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
IARC, . Schistosomes Liver Flukes and
Hericobactor pylori. IARC Sci. 1994.
|
|
5
|
Tsukamoto T and Tatematsu M: Role of
Helicobacter pylori in gastric neoplasia. Curr Infect Dis
Rep. 16:4022014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sukawa Y, Yamamoto H, Nosho K, et al:
Alterations in the human epidermal growth factor receptor
2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.
World J Gastroenterol. 18:6577–6586. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Berg M and Soreide K: EGFR and downstream
genetic alterations in KRAS/BRAF and PI3K/AKT pathways in
colorectal cancer: implications for targeted therapy. Discov Med.
14:207–214. 2012.PubMed/NCBI
|
|
8
|
Ng L, Poon RT and Pang R: Biomarkers for
predicting future metastasis of human gastrointestinal tumors. Cell
Mol Life Sci. 70:3631–3656. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheung M and Testa JR: Diverse mechanisms
of AKT pathway activation in human malignancy. Curr Cancer Drug
Targets. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Downward J: PI 3-kinase, Akt and cell
survival. Semin Cell Dev Biol. 15:177–182. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Radisavljevic Z: AKT as locus of cancer
angiogenic robustness and fragility. J Cell Physiol. 228:21–24.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu M and Mo YY: The Akt-associated
microRNAs. Cell Mol Life Sci. 69:3601–3612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sasaki T, Kuniyasu H, Luo Y, et al:
Increased phosphorylation of AKT in high-risk gastric mucosa.
Anticancer Res. 33:3295–3300. 2013.PubMed/NCBI
|
|
14
|
Ho SB: Premalignant lesions of the
stomach. Semin Gastrointest Dis. 7:61–73. 1996.PubMed/NCBI
|
|
15
|
Hatakeyama M: Oncogenic mechanisms of the
Helicobacter pylori CagA protein. Nat Rev Cancer. 4:688–694.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Higashi H, Tsutsumi R, Muto S, et al:
SHP-2 tyrosine phosphatase as an intracellular target of
Helicobacter pylori CagA protein. Science. 295:683–686.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
You M, Yu DH and Feng GS: Shp-2 tyrosine
phosphatase functions as a negative regulator of the
interferon-stimulated Jak/STAT pathway. Mol Cell Biol.
19:2416–2424. 1999.PubMed/NCBI
|
|
18
|
Tosh D and Slack JM: How cells change
their phenotype. Nat Rev Mol Cell Biol. 3:187–194. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ochiai A and Hirohashi S: Genetic
alteration in the precursors of gastric cancerMol Pathol
Gastroenterol Cancer. Tahara E: Springer-Verlag; Tokyo: pp. 43–53.
1997
|
|
20
|
Sugano K: Premalignant conditions of
gastric cancer. J Gastroenterol Hepatol. 28:906–911. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Testino G: Helicobacter pylori,
cell proliferation and carcinogenesis. Am J Gastroenterol.
96:25142001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guerci A, Chambre JF, Franck P, Floquet J,
Gaucher P and Guerci O: Flow cytometric analysis of the cell cycle
in chronic gastritis. Anal Cell Pathol. 4:381–388. 1992.PubMed/NCBI
|
|
23
|
Tahara E, Kuniyasu H, Yasui W and Yokozaki
H: Gene alterations in intestinal metaplasia and gastric cancer.
Eur J Gastroenterol Hepatol. (6 Suppl 1):1021994.
|
|
24
|
Ochiai A, Yamauchi Y and Hirohashi S: p53
mutations in the non-neoplastic mucosa of the human stomach showing
intestinal metaplasia. Int J Cancer. 69:28–33. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Semba S, Yokozaki H, Yamamoto S, Yasui W
and Tahara E: Microsatellite instability in precancerous lesions
and adenocarcinomas of the stomach. Cancer. 77:1620–1627. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blackburn EH: Switching and signaling at
the telomere. Cell. 106:661–673. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lingner J, Cooper JP and Cech TR:
Telomerase and DNA end replication: no longer a lagging strand
problem? Science. 269:1533–1534. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stewart SA and Weinberg RA: Telomeres:
cancer to human aging. Annu Rev Cell Dev Biol. 22:531–557. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tahara H, Kuniyasu H, Yokozaki H, et al:
Telomerase activity in preneoplastic and neoplastic gastric and
colorectal lesions. Clin Cancer Res. 1:1245–1251. 1995.PubMed/NCBI
|
|
30
|
Feng J, Funk WD, Wang SS, et al: The RNA
component of human telomerase. Science. 269:1236–1241. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Avilion AA, Piatyszek MA, Gupta J, Shay
JW, Bacchetti S and Greider CW: Human telomerase RNA and telomerase
activity in immortal cell lines and tumor tissues. Cancer Res.
56:645–650. 1996.PubMed/NCBI
|
|
32
|
Blasco MA, Rizen M, Greider CW and Hanahan
D: Differential regulation of telomerase activity and telomerase
RNA during multi-stage tumorigenesis. Nat Genet. 12:200–204. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kuniyasu H, Domen T, Hamamoto T, et al:
Expression of human telomerase RNA is an early event of stomach
carcinogenesis. Jpn J Cancer Res. 88:103–107. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weiss H, Gutz HJ, Schroter J and Wildner
GP: DNA distribution pattern in chronic gastritis. I. DNA ploidy
and cell cycle distribution. Scand J Gastroenterol. 24:643–648.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kuniyasu H, Kitadai Y, Mieno H and Yasui
W: Helicobactor pylori infection is closely associated with
telomere reduction in gastric mucosa. Oncology. 65:275–282. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Autexier C and Lue NF: The structure and
function of telomerase reverse transcriptase. Annu Rev Biochem.
75:493–517. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Angrisano T, Lembo F, Peluso S, Keller S,
Chiariotti L and Pero R: Helicobacter pylori regulates iNOS
promoter by histone modifications in human gastric epithelial
cells. Med Microbiol Immunol. 201:249–257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Murata M, Thanan R, Ma N and Kawanishi S:
Role of nitrative and oxidative DNA damage in inflammation-related
carcinogenesis. J Biomed Biotechnol. 2012:6230192012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Beales IL, Ogunwobi O, Cameron E, El-Amin
K, Mutungi G and Wilkinson M: Activation of Akt is increased in the
dysplasia-carcinoma sequence in Barrett's oesophagus and
contributes to increased proliferation and inhibition of apoptosis:
a histopathological and functional study. BMC Cancer. 7:972007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li H, Zhao L, Yang Z, Funder JW and Liu
JP: Telomerase is controlled by protein kinase C alpha in human
breast cancer cells. J Biol Chem. 273:33436–33442. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kang SS, Kwon T, Kwon DY and Do SI: Akt
protein kinase enhances human telomerase activity through
phosphorylation of telomerase reverse transcriptase subunit. J Biol
Chem. 274:13085–13090. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim JH, Park SM, Kang MR, et al: Ubiquitin
ligase MKRN1 modulates telomere length homeostasis through a
proteolysis of hTERT. Genes Dev. 19:776–781. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sasaki T, Kuniyasu H, Luo Y, et al: AKT
activation and telomerase reverse transcriptase expression are
concurrently associated with prognosis of gastric cancer.
Pathobiology. 81:36–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Populo H, Lopes JM and Soares P: The mTOR
Signalling Pathway in Human Cancer. Int J Mol Sci. 13:1886–1918.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Karamitopoulou E: Tumor budding cells,
cancer stem cells and epithelial-mesenchymal transition-type cells
in pancreatic cancer. Front Oncol. 2:2092012.PubMed/NCBI
|
|
46
|
Liu Z, Li Q, Li K, et al: Telomerase
reverse transcriptase promotes epithelial-mesenchymal transition
and stem cell-like traits in cancer cells. Oncogene. 32:4203–4213.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fidler IJ: The pathogenesis of cancer
metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Claesson-Welsh L and Welsh M: VEGFA and
tumour angiogenesis. J Intern Med. 273:114–127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Karar J and Maity A: PI3K/AKT/mTOR Pathway
in Angiogenesis. Front Mol Neurosci. 4:512011. View Article : Google Scholar : PubMed/NCBI
|
